According to a study presented at the American Academy of Ophthalmology’s annual meeting in Chicago, investigational ...
This included a sponsor fee waiver and an Investigational New Animal Drug number (INAD) for its animal health applications from the FDA Center for Veterinary Medicine. Iris Bincovich, CEO of Innocan ...
Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced that the U.S. Food and Drug ...
Oregon decriminalized hard drugs in 2021 and recriminalized them last month. A new analysis shows the laws likely had little ...
In the wake of Pfizer’s voluntary market withdrawal of the popular sickle cell disease therapy, BioSpace looks at five investigational drugs currently making their way through the pipeline.
TipRanks on MSN15h
CStone Pharmaceuticals Unveils Patent for Innovative Cancer TherapyCStone Pharmaceuticals (HK:2616) has released an update. CStone Pharmaceuticals has announced the publication of a patent for ...
Gilead Sciences (GILD) and Merck (MRK) announced new results from a Phase 2 clinical study evaluating the investigational combination of ...
Gilead Sciences, Inc. (Nasdaq: GILD) and Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today ...
Experts explored the latest trends, approvals, and pipeline developments in cell and gene therapies, rare disease, immunology ...
The FDA approved the company's COVID vaccine in October 2023. The stock has gained 111% in the year to date, while the S&P 500 SPX has gained 22%. This content was created by MarketWatch, which is ...
On Thursday, Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) announced that the United States Patent and Trademark Office has ...
A recent study suggests that a drug approved for the treatment of seizures may also help treat Alzheimer's in people who do ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback